Virpax selects Altasciences to develop a drug to prevent the spread of flu like viruses
AnQlar is a nanoparticle intended to help prevent the spread of negatively charged viruses such as COVID-19 and influenza...
top of page
Upload a PDF
Max File Size 15MB
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Medical Device News
- Sep 20
- 2 min
Santa Barbara Surgery Center, first in SoCal, to Adopt New Wireless Arthroscopy Technology
With the new wireless ArthroFree system, there are no cords to distract a surgeon’s attention so they can maintain their full concentration
- Sep 15
- 4 min
Aclipse Therapeutics Expands Drug Development Pipeline for Gastroparesis
Aclipse Therapeutics is an innovative biopharmaceutical company developing life-changing treatments for patients with severe diseases.
- Sep 13
- 5 min
Zevra Therapeutics Presents Full Data Set on the Cardiovascular Safety and Pharmacokinetics of SDX
These data play an important role in the development of KP1077 as we address the unmet needs of people living with rare sleep disorders
- Sep 12
- 4 min
Shine Technologies and Curadh MTR Expand Partnership for Cancer Therapies using Terbium and Lutetium
Curadh intends to focus its beta development with this novel isotope in molecularly targeted therapies for solid tumors.
- Sep 5
- 4 min
Irish hospital group Blackrock Health Announces €25 million investment in digital transformation
Blackrock Health employs more than 2,800 staff and provides access for patients to 600 highly skilled staff in 50 specialties.
- Aug 30
- 3 min
Questa Capital closes a $397 million fund to invest in expansion stage healthcare companies
Questa Capital III will invest in growth companies in 3 healthcare sectors: services, technology and medical devices.
- Aug 28
- 3 min
Inhibikase Therapeutics develops novel formulation of risvodetinib
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease...
- Aug 25
- 3 min
Botanical Solution raises an additional $7 Million to scale up production of vaccine adjuvants
Botanical Solution has a proprietary platform for sustainable and improved production of high quality Advanced Botanical Materials (ABMs)
- Aug 18
- 4 min
Novo Holdings participates in $290 million strategic financing of Sangon Biotech
Shanghai Sangon Biotech is a provider with comprehensive portfolio coverage in the life sciences research product and service industries
- Aug 15
- 3 min
IRA Capital Launches $500 Million Healthcare Real Estate Fund
The Fund will focus on the acquisition, development, and financing of well-located healthcare assets in high barrier-to-entry markets
- Aug 7
- 2 min
AI-driven pioneer in drug formulation, Persist AI, raises $4 million
Persist AI specializes in building and optimizing long-acting injectable formulations
- Aug 4
- 3 min
Adamis Pharmaceuticals prices $8 million public offering
Adamis’ commercial products approved by the FDA include ZIMHI® (naloxone) Injection for the treatment of opioid overdose,
- Jul 24
- 3 min
PainReform, a clinical-stage specialty pharmaceutical company prices $2.7 million financing
PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure
- Jul 19
- 2 min
Clinical stage biopharmaceutical company Galmed Pharmaceuticals prices $7 million public offering
Galmed Pharmaceuticals has focused almost exclusively on developing Aramchol for the treatment of NASH.
- Jul 18
- 3 min
CurvaFix obtains $39 million to expand treatment of fragility fractures of the pelvis
CurvaFix is developing implantable products to improve fracture repair in curved bones and is focusing on Fragility Fractures of the Pelvis
- Jul 13
- 2 min
Parker Health raises $25 Million to transform American healthcare
Parker Health is simplifying the complexities of healthcare and deliver on the unfulfilled promises of digital health innovation,
- Jul 7
- 3 min
Liberate Medical raises $6.2 million to support trials of its VentFree Respiratory Muscle Stimulator
Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology
- Jul 3
- 3 min
Medical device company Tenon Medical prices $5.6 Million public offering
Tenon has developed The Catamaran SI Joint Fusion System provides a less invasive approach to the SI joint using a single, titanium implant.
- Jun 26
- 6 min
Tagworks Pharmaceuticals closes a $65 Million financing to advance its Click-to-Release therapeutics
Tagworks Pharmaceuticals, pioneer of the Click-to-Release approach, is a precision therapy company.
- Jun 21
- 6 min
Turbine, which uses cell simulations increases its current financing to €25.5 million
Turbine's vision is to overcome the limitations in identifying oncology treatments with patient benefit by combining molecular biology...
- Jun 19
- 3 min
RK Pharma wraps up acquisition of developer of clinical critical therapies VGYAAN Pharmaceuticals
RK Pharma focuses on the development, manufacturing, and sale of high quality and affordable generic pharmaceutical products worldwide.
- Jun 13
- 4 min
HanAll Biopharma and Daewoong Pharmaceutical invest in Vincere Biosciences for Parkinson's Research
This partnership highlights the joining of forces across a shared mission to deliver disease-modifying medicines for Parkinson's disease.
- Jun 7
- 8 min
CERo Therapeutics to merge with SPAC and advance engineered T Cell therapeutics
Phoenix Biotech Acquisition Corp. (NASDAQ: PBAX) is a blank-check company formed for the purpose of effecting a merger, share exchange...
- Jun 2
- 5 min
Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure
Alleviant’s mission is to bring a safe, effective no-implant treatment option to millions of patients suffering from heart failure.
- May 26
- 4 min
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons
. NurrOn is focused on the discovering and developing novel therapies for people with neurodegenerative diseases including Parkinson's...
- May 22
- 6 min
Startups Wanted: Catalyst by Wellstar Launches $100 Million Fund to Shape Future of Healthcare
Wellstar will directly influence the problems addressed and solutions created by the nation's most promising startups and entrepreneurs.
- May 19
- 3 min
Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
- May 18
- 6 min
HealthSnap closes $9 Million for its remote patient monitoring and chronic care management platform
HealthSnap is an integrated virtual care management platform that helps healthcare organizations improve patient outcomes...
- May 15
- 2 min
Sealonix raises $20 Million to develop sealants for abdominopelvic and orthopedic procedures
The PramStat patch builds on many years of research done by this experienced team, and now will move rapidly into clinical development.
- May 12
- 6 min
Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction
Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate
- May 11
- 3 min
Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology
DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.
- May 6
- 6 min
MultiOmic Health Closes $6.2 Million for precision medicines for metabolic syndrome conditions
The proceeds of this financing will be used to demonstrate proof-of-concept for MultiOmic’s MOHSAIC platform in diabetic kidney disease
- May 5
- 3 min
Galmed Pharmaceuticals and OnKai partner for clinical studies in underserved communities
Through this partnership, the companies intend to facilitate faster clinical trial enrollment and provide patients with access to medicines
- May 4
- 4 min
Magenta Medical raises $55 million to advance the world's smallest heart pump
Magenta's Elevate™ percutaneous left ventricular assist device is currently in clinical testing
- May 3
- 4 min
Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials
We significantly grew our clinical trial programs for central nervous system cancers in 2022 and we expect to continue this momentum
- Apr 27
- 4 min
Mezzion Pharma raises $40 million for its first-to-market treatment for fontan patients
The average life expectancy for a Fontan patient is 35-45 and apart from JURVIGO, there are currently no other pharmacotherapies available
- Apr 25
- 2 min
ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP
ANI Pharmaceuticals (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing,
- Apr 24
- 4 min
Artificial intelligence Digital Diagnostics now available at nine Labcorp centers
Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform global health care.
- Apr 21
- 3 min
Gale Healthcare partners with Smartlinx to address America's nursing shortage
Gale has one of the fastest growing networks of supplemental clinicians in the country and serves thousands of healthcare clients...
- Apr 20
- 3 min
Singapore-based Ross Swan joins FC Global Strategies as Managing Director, Asia-Pacific
Medical and Pharma Insider is a program of FC Global Strategies.
- Apr 19
- 2 min
Medical device company, BioVentrix closes on $48.5 million to improve cardiac function
BioVentrix is a medical device company focused on the development of less invasive therapies to treat the failing left ventricle.
- Apr 18
- 4 min
Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases
Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases
- Apr 17
- 3 min
Professional Health Care Network rebrands as "Tango" and expands its strategic partnerships
Tango's services provide higher quality care, improved access, better patient outcomes, and reduced total costs...
- Apr 14
- 4 min
Novo Holdings participates in $105 million funding in Alentis Therapeutics
Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.
- Apr 10
- 5 min
OXOS Medical raises $23 million for its “Radiology Department in a Box”
With a low radiation profile, the OXOS smart devices provide outstanding image sharpness and clarity in the smallest form factor.
- Apr 3
- 3 min
Orion is building a pharmaceutical research ecosystem using data and artificial intelligence
Artificial intelligence-guided use of data is a competitive advantage when developing new innovative medicines.
- Mar 30
- 3 min
Viking Therapeutics prices $250 Million public common stock offering
Viking Therapeutics is a clinical-stage biopharmaceutical company that is developing novel first-in-class or best-in-class therapies
- Mar 28
- 3 min
EpiBiologics raises $50 million for next-generation antibody-based protein degradation platform
EpiBiologics is building a next-generation protein degradation platform that targets membrane and extracellular proteins.
- Mar 27
- 3 min
Reveal HealthTech raises $4 million to provide healthcare organizations with engineering support
Reveal HealthTech provides specialized engineering, clinical model, and strategy support to healthcare organizations in the US and worldwide
bottom of page